0QCV · AbbVie, Inc.
285.82
USDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
US$505.08B
PE
96.80
EV/EBITDA
16.1
DIV Yield
2.9%
Payout Ratio
200%
MQV Rating
5Very Weak
As at 15/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- Near Resistance
Key Fundamentals
EPS 3 yr Growth
-64.40%
EBITDA Margin
47.50%
Operating Cashflow
$19,030m
Free Cash Flow Return
31.50%
ROIC
6.90%
Interest Coverage
9.50
Quick Ratio
0.60
Performance
52 weeks range
Low 186.49 - 292.5
Trade Value (12mth)
US$872,810.00
1 week
5.61%
1 month
8.86%
YTD
24.58%
1 year
24.46%
All time high
292.50
Additional Data
Shares Outstanding (Fully Diluted)
1,771m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
14-Oct-26
Next Dividend Pay Date
16-Nov-26
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
Key Stakeholders
| Name | Title |
| Richard A. Gonzalez | Individual |
| Azita Saleki-Gerhardt | Individual |
| Robert A. Michael | Individual |
| Employees Provident Fund (Investment Management) | Operating Division |
| Thomas C. Freyman | Individual |
